You are here

Article Text

Article menu

This article has a Reply. Please see:

Download PDFPDF
Correspondence
Correspondence on “Update on the diagnosis and management of systemic lupus erythematosus”
  1. Zhuochao Zhou,
  2. Yijun You,
  3. Fan Wang,
  4. Yue Sun,
  5. Jialin Teng,
  6. Honglei Liu,
  7. Xiaobing Cheng,
  8. Yutong Su,
  9. Hui Shi,
  10. Chengde Yang,
  11. Junna Ye
  1. Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
  1. Correspondence to Dr Junna Ye, Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; yjn0912{at}qq.com; Dr Chengde Yang, Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; yangchengde{at}sina.com

http://dx.doi.org/10.1136/annrheumdis-2021-220897

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    This review1 provided a comprehensive update on recent developments in systemic lupus erythematosus (SLE) and proposed several new viewpoints. In terms of diagnosis, the authors were the first to put forward two types of clinical SLE, in addition to classified SLE. Particularly, in the European League Against Rheumatism (EULAR)/American College of Rheumatology score <10 category in figure 4, the authors suggested that an immunological score of ≥2 together with a clinical score of ≥6 …

    View Full Text

    Footnotes

    • ZZ and YY contributed equally.

    • Contributors Study conception and manuscript writing: JY, CY, ZZ and YY. Manuscript revisions: JT, HL, XC, YS, HS and FW.

    • Funding This work was supported by the National Natural Science Foundation of China (81801592) and Clinical Research Plan of SHDC (SHDC2020CR4011).

    • Competing interests None declared.

    • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles